Biomed Central Ltd

SHERPA: Unknown

People

  1. Vickers
    Vickers
  2. Postow
    Postow
  3. D'Angelo
    D'Angelo
  4. Offit
    Offit
  5. Budhu
    Budhu
  6. Motzer
    Motzer
  7. Shoushtari
    Shoushtari
  8. Cheung
    Cheung
  9. Voss
    Voss
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (560)
  2. Solid Tumor Oncology Division (456)
  3. GSK Faculty (293)
  4. Sloan Kettering Institute Postdocs (193)
  5. Population Sciences Research Program (157)
  6. Hematologic Malignancies, Division of (155)
  7. Epidemiology and Biostatistics (152)
  8. Melanoma and Immunotherapeutics Service (148)
  9. Survivorship Research (120)
  10. Surgery (119)
Search Within
Formats
  1. Journal Article (745)
  2. Meeting Abstract (257)
  3. Review (40)
  4. Guidelines (20)
  5. Editorial (10)
  6. Research Letter (7)
  7. Correspondence (4)
  8. Conference Paper (1)
  9. Miscellaneous (1)
Groups
  1. Department of Medicine (560)
  2. Solid Tumor Oncology Division (456)
  3. GSK Faculty (293)
  4. Sloan Kettering Institute Postdocs (193)
  5. Population Sciences Research Program (157)
  6. Hematologic Malignancies, Division of (155)

More Groups

People
  1. Jedd Wolchok (83)
  2. Taha Merghoub (55)
  3. Andrew Vickers (44)
  4. Michael Postow (43)
  5. Matthew Hellmann (30)
  6. Sandra D'Angelo (25)

More People

Years
  1. 2025 (33)
  2. 2024 (60)
  3. 2023 (44)
  4. 2022 (122)
  5. 2021 (91)
  6. 2020 (99)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (407)
  2. Breast Cancer Research (67)
  3. BMC Cancer (64)
  4. Genome Biology (47)
  5. Journal of Hematology & Oncology (43)
  6. Journal of Translational Medicine (35)

More Publications

Results (1085)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Circulating bilirubin levels and risk of colorectal cancer: Serological and Mendelian randomization analyses
    Journal Article

    Seyed Khoei, N.; Jenab, M.; Murphy, N.; Banbury, B. L.; Carreras-Torres, R.; Viallon, V.; Kühn, T.; Bueno-de-Mesquita, B.; Aleksandrova, K.; Cross, A. J.; more...
    BMC Medicine (2020)

    Fulltext@MSK | Save
  • Outcomes to first-line pembrolizumab in patients with PD-L1-high (≥50%) non-small cell lung cancer and a poor performance status
    Journal Article

    Alessi, J. V.; Ricciuti, B.; Jiménez-Aguilar, E.; Hong, F.; Wei, Z.; Nishino, M.; Plodkowski, A. J.; Sawan, P.; Luo, J.; Rizvi, H.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Patient reported outcome data from acromegaly patients treated with injectable somatostatin receptor ligands (SRLs) in routine clinical practice
    Journal Article

    Geer, E. B.; Sisco, J.; Adelman, D. T.; Ludlam, W. H.; Haviv, A.; Liu, S.; Mathias, S. D.; Gelbaum, D.; Shi, L.
    BMC Endocrine Disorders (2020)

    Fulltext@MSK | Save
  • Comparison of up-front cash cards and checks as incentives for participation in a clinician survey: A study within a trial
    Journal Article

    Pace, L. E.; Lee, Y. S.; Tung, N.; Hamilton, J. G.; Gabriel, C.; Raja, S. C.; Jenkins, C.; Braswell, A.; Domchek, S. M.; Symecko, H.; more...
    BMC Medical Research Methodology (2020)

    Fulltext@MSK | Save
  • MRI background parenchymal enhancement, fibroglandular tissue, and mammographic breast density in patients with invasive lobular breast cancer on adjuvant endocrine hormonal treatment: Associations with survival
    Journal Article

    Lo Gullo, R.; Daimiel, I.; Rossi Saccarelli, C.; Bitencourt, A.; Sevilimedu, V.; Martinez, D. F.; Jochelson, M. S.; Morris, E. A.; Reiner, J. S.; Pinker, K.
    Breast Cancer Research (2020)

    Fulltext@MSK | Save
  • Technology-enabled activation of skin cancer screening for hematopoietic cell transplantation survivors and their primary care providers (TEACH)
    Journal Article

    Armenian, S. H.; Lindenfeld, L.; Iukuridze, A.; Echevarria, M.; Bebel, S.; Coleman, C.; Nakamura, R.; Abdullah, F.; Modi, B.; Oeffinger, K. C.; more...
    BMC Cancer (2020)

    Fulltext@MSK | Save
  • Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial
    Journal Article

    Motzer, R. J.; Escudier, B.; McDermott, D. F.; Frontera, O. A.; Melichar, B.; Powles, T.; Donskov, F.; Plimack, E. R.; Barthélémy, P.; Hammers, H. J.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma
    Guidelines

    Shah, N.; Aiello, J.; Avigan, D. E.; Berdeja, J. G.; Borrello, I. M.; Chari, A.; Cohen, A. D.; Ganapathi, K.; Gray, L.; Green, D.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • DNA damage repair pathway alterations in metastatic clear cell renal cell carcinoma and implications on systemic therapy
    Journal Article

    Ged, Y.; Chaim, J. L.; DiNatale, R. G.; Knezevic, A.; Kotecha, R. R.; Carlo, M. I.; Lee, C. H.; Foster, A.; Feldman, D. R.; Teo, M. Y.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: A multicenter, retrospective study
    Journal Article

    Najjar, Y. G.; Navrazhina, K.; Ding, F.; Bhatia, R.; Tsai, K.; Abbate, K.; Durden, B.; Eroglu, Z.; Bhatia, S.; Park, S.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save